{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:05:15Z","timestamp":1780067115086,"version":"3.54.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Norwegian Institute of Biomedical Science"},{"name":"Fondsstiftelsen"},{"DOI":"10.13039\/100031365","name":"Oslo University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Biochemical diagnostic approach for acromegaly relies heavily on the 2 biomarkers, growth hormone (GH) and insulin like growth factor 1 (IGF1), known to be dynamically affected, and influencing diagnostic accuracy. We sought to identify disease-specific biomarkers to improve diagnostic and disease activity monitoring and add insight into systemic effects of chronic GH\/IGF1 excess.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-seven patients diagnosed with acromegaly were enrolled. A sub-cohort (n = 14) of these received primary somatostatin receptor ligand (SRL) treatment before surgery. Plasma samples collected at baseline, preoperative medical treatment and postoperative visits, were used to perform proteomic analysis of 184 proteins, with Olink Target 96 Cardiovascular III and Inflammation panels. Eight proteins were validated Enzyme Immunoassay (EIA). Dual-energy X-ray absorptiometry and biochemical measurements were performed at all visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 37 proteins were significantly differentially expressed (P-adjusted &amp;lt; .05) before and after disease control by surgery. Several proteins correlated with GH and IGF1. Interestingly, a strong correlation between some proteins and lean body mass, but not total adipose tissue, was observed. Strong correlation was observed between Olink and EIA measured protein levels. Enrichment analyses revealed 5 clusters, with extracellular matrix (ECM) remodeling and inflammation being most prominent. In addition, 5 proteins showed a temporal change with SRL treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Acromegaly is associated with changes in ECM remodeling and inflammation. Several proteins were linked to disease activity, with glial cell derived neurotrophic factor and insulin like growth factor binding protein 2 serving as promising plasma biomarkers with potential to further optimize management of disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag083","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:18:31Z","timestamp":1778498311000},"page":"732-743","source":"Crossref","is-referenced-by-count":0,"title":["Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly"],"prefix":"10.1093","volume":"194","author":[{"given":"Kristin","family":"Godang","sequence":"first","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9371-2359","authenticated-orcid":false,"given":"Maren Ileby","family":"Wessel","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]},{"name":"Faculty of Medicine, University of Oslo , 0372 Oslo ,","place":["Norway"]},{"name":"Research Institute of Internal Medicine, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Khan","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-0784","authenticated-orcid":false,"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo , 0372 Oslo ,","place":["Norway"]},{"name":"Research Institute of Internal Medicine, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]},{"name":"Department of Cardiothoracic and Vascular Surgery, University Hospital of North Norway , 9019 Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Lekva","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Petter","family":"Berg","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo , 0372 Oslo ,","place":["Norway"]},{"name":"Department of Medical Biochemistry, Oslo University Hospital , 0450 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-4610","authenticated-orcid":false,"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9436-539X","authenticated-orcid":false,"given":"Nicoleta Cristina","family":"Olarescu","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"1","key":"2026052910215859600_lvag083-B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17446651.2024.2448784","article-title":"Acromegaly: diagnostic challenges and individualized treatment","volume":"20","author":"Freda","year":"2025","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"2026052910215859600_lvag083-B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","article-title":"Consensus on criteria for acromegaly diagnosis and remission","volume":"27","author":"Giustina","year":"2024","journal-title":"Pituitary"},{"issue":"11","key":"2026052910215859600_lvag083-B3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2026052910215859600_lvag083-B4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cen.14917","article-title":"Elevated insulin-like growth factor-1 in patients without clinical evidence of acromegaly","volume":"99","author":"Careless","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026052910215859600_lvag083-B5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2265.2009.03556.x","article-title":"Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?","volume":"71","author":"Freda","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026052910215859600_lvag083-B6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-19-0139","article-title":"Determinants of the growth hormone nadir during oral glucose tolerance test in adults","volume":"181","author":"Schilbach","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026052910215859600_lvag083-B7","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1210\/jc.2007-2780","article-title":"Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly","volume":"93","author":"Freda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026052910215859600_lvag083-B8","doi-asserted-by":"publisher","first-page":"K37","DOI":"10.1093\/ejendo\/lvae016","article-title":"Long-term depot specific changes in adipose tissue after treatment of acromegaly","volume":"190","author":"Falch","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026052910215859600_lvag083-B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103763","article-title":"Reversible insulin resistance in muscle and fat unrelated to the metabolic syndrome in patients with acromegaly","volume":"75","author":"Arlien-Soborg","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"2026052910215859600_lvag083-B10","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1210\/jc.2009-2570","article-title":"Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control","volume":"95","author":"Berg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026052910215859600_lvag083-B11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11154-020-09560-x","article-title":"Acromegaly, inflammation and cardiovascular disease: a review","volume":"21","author":"Wolters","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2026052910215859600_lvag083-B12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ejendo\/lvad031","article-title":"Gene expression profiling of subcutaneous adipose tissue reveals new biomarkers in acromegaly","volume":"188","author":"Falch","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026052910215859600_lvag083-B13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41574-024-00993-x","article-title":"Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management","volume":"20","author":"Esposito","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2026052910215859600_lvag083-B14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tem.2016.02.005","article-title":"The impact of adipose tissue on insulin resistance in acromegaly","volume":"27","author":"Olarescu","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"2026052910215859600_lvag083-B15","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41374-022-00830-7","article-title":"High-throughput proteomics: a methodological mini-review","volume":"102","author":"Cui","year":"2022","journal-title":"Lab Invest"},{"key":"2026052910215859600_lvag083-B16","doi-asserted-by":"publisher","DOI":"10.4061\/2009\/239204","article-title":"Proteomics: challenges, techniques and possibilities to overcome biological sample complexity","volume":"2009","author":"Chandramouli","year":"2009","journal-title":"Hum Genomics Proteomics"},{"issue":"5","key":"2026052910215859600_lvag083-B17","doi-asserted-by":"publisher","DOI":"10.1002\/prca.202300233","article-title":"Methods and clinical biomarker discovery for targeted proteomics using Olink technology","volume":"18","author":"Wang","year":"2024","journal-title":"Proteomics Clin Appl"},{"issue":"4","key":"2026052910215859600_lvag083-B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2026052910215859600_lvag083-B19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jocd.2021.07.002","article-title":"The influence of Dxa hardware, software, reference population and software analysis settings on the bone mineral density and T-score relationship","volume":"25","author":"Lundstam","year":"2022","journal-title":"J Clin Densitom"},{"issue":"8","key":"2026052910215859600_lvag083-B20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.ejcn.1601633","article-title":"Cross-calibration of GE\/lunar pencil and fan-beam dual energy densitometers\u2013bone mineral density and body composition studies","volume":"57","author":"Oldroyd","year":"2003","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"2026052910215859600_lvag083-B21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jocd.2010.01.121","article-title":"Assessing body composition in healthy newborn infants: reliability of dual-energy x-ray absorptiometry","volume":"13","author":"Godang","year":"2010","journal-title":"J Clin Densitom"},{"issue":"9","key":"2026052910215859600_lvag083-B22","doi-asserted-by":"publisher","first-page":"E1727","DOI":"10.1210\/jc.2014-2059","article-title":"Dual-energy X-ray absorptiometry is a valid method to estimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone","volume":"99","author":"Olarescu","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026052910215859600_lvag083-B23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/cpf.12152","article-title":"Contemporary methods of body composition measurement","volume":"35","author":"Fosbol","year":"2015","journal-title":"Clin Physiol Funct Imaging"},{"issue":"4","key":"2026052910215859600_lvag083-B24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1210\/jc.2011-2417","article-title":"Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase\/visfatin in active acromegaly","volume":"97","author":"Olarescu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026052910215859600_lvag083-B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-13-0523","article-title":"Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities","volume":"170","author":"Olarescu","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026052910215859600_lvag083-B26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12603-014-0012-8","article-title":"Precision of total and regional body fat estimates from dual-energy X-ray absorptiometer measurements","volume":"18","author":"Kaminsky","year":"2014","journal-title":"J Nutr Health Aging"},{"key":"2026052910215859600_lvag083-B27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4125013","article-title":"Pre- and postoperative body composition and metabolic characteristics in patients with acromegaly: a prospective study","volume":"2018","author":"Guo","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2026052910215859600_lvag083-B28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11005\/jbm.2024.31.3.182","article-title":"Body composition, sarcopenia, and Serum myokines in acromegaly: a narrative review","volume":"31","author":"Inojosa","year":"2024","journal-title":"J Bone Metab"},{"issue":"3","key":"2026052910215859600_lvag083-B29","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"2026052910215859600_lvag083-B30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ghir.2004.06.002","article-title":"Bone metabolism in relation to alterations in systemic growth hormone","volume":"14","author":"Ueland","year":"2004","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"2026052910215859600_lvag083-B31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","article-title":"Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization","volume":"26","author":"Sandberg","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2026052910215859600_lvag083-B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/ar134","article-title":"The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption","volume":"3","author":"Gravallese","year":"2001","journal-title":"Arthritis Res"},{"issue":"7","key":"2026052910215859600_lvag083-B33","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Golledge","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"2026052910215859600_lvag083-B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05654-w","article-title":"CCL11, a novel mediator of inflammatory bone resorption","volume":"7","author":"Kindstedt","year":"2017","journal-title":"Sci Rep"},{"key":"2026052910215859600_lvag083-B35","doi-asserted-by":"publisher","DOI":"10.31083\/RCM26020","article-title":"CCL11 (eotaxin) promotes the advancement of aging-related cardiovascular diseases","volume":"26","author":"Zhang","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"2026052910215859600_lvag083-B36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1618330","article-title":"Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential","volume":"16","author":"Porcari","year":"2025","journal-title":"Front Physiol"},{"issue":"1","key":"2026052910215859600_lvag083-B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physiol.00009.2025","article-title":"Growth hormone and IGF-1 actions in the brain and neuropsychiatric diseases","volume":"41","author":"Aguiar-Oliveira","year":"2026","journal-title":"Physiology (Bethesda)"},{"key":"2026052910215859600_lvag083-B38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ebiom.2019.04.007","article-title":"Unmasking a new prognostic marker and therapeutic target from the GDNF-RET\/PIT1\/p14ARF\/p53 pathway in acromegaly","volume":"43","author":"Chenlo","year":"2019","journal-title":"EBioMedicine"},{"issue":"5","key":"2026052910215859600_lvag083-B39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/0026-0495(94)90199-6","article-title":"Insulin-like growth factors (IGF)-I and -II and IGF binding protein-1, -2, and -3 in patients with acromegaly before and after adenomectomy","volume":"43","author":"Jorgensen","year":"1994","journal-title":"Metabolism"},{"issue":"11","key":"2026052910215859600_lvag083-B40","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1210\/jcem.85.11.6964","article-title":"The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 study group","volume":"85","author":"Dall","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026052910215859600_lvag083-B41","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1038\/s41388-020-1154-2","article-title":"IGFBP2: integrative hub of developmental and oncogenic signaling network","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"issue":"3","key":"2026052910215859600_lvag083-B42","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1210\/endo.132.3.7679979","article-title":"Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I\/insulin hybrid, and IGF-I analogs","volume":"132","author":"Oh","year":"1993","journal-title":"Endocrinology"},{"issue":"9","key":"2026052910215859600_lvag083-B43","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1210\/jc.2017-00558","article-title":"Glucagon decreases IGF-1 bioactivity in humans, independently of insulin, by modulating its binding proteins","volume":"102","author":"Sarem","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026052910215859600_lvag083-B44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12020-017-1283-8","article-title":"Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients","volume":"57","author":"Karci","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"2026052910215859600_lvag083-B45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ejendo\/lvag032","article-title":"Growth hormone causes reversible fibrosis in muscle and fat: a study in patients with acromegaly","volume":"194","author":"Baek","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026052910215859600_lvag083-B46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1006\/bbrc.2001.4323","article-title":"Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP","volume":"281","author":"Hernandez-Barrantes","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2026052910215859600_lvag083-B47","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3892\/mmr.2020.11358","article-title":"Decrease in matrix metalloproteinase-3 activity in systemic sclerosis fibroblasts causes alpha2-antiplasmin and extracellular matrix deposition, and contributes to fibrosis development","volume":"22","author":"Niwa","year":"2020","journal-title":"Mol Med Rep"},{"issue":"9","key":"2026052910215859600_lvag083-B48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41574-022-00702-6","article-title":"Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer","volume":"18","author":"Kopchick","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2026052910215859600_lvag083-B49","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3906\/sag-2011-317","article-title":"Fatty acid-binding protein-4 as a biomarker predicting acromegaly-associated diabetes mellitus","volume":"51","author":"Hepsen","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"2","key":"2026052910215859600_lvag083-B50","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/JOE-18-0174","article-title":"Chemerin: a multifaceted adipokine involved in metabolic disorders","volume":"238","author":"Helfer","year":"2018","journal-title":"J Endocrinol"},{"issue":"3-4","key":"2026052910215859600_lvag083-B51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000371818","article-title":"The metabolic risk in patients newly diagnosed with acromegaly is related to fat distribution and circulating adipokines and improves after treatment","volume":"103","author":"Olarescu","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026052910215859600_lvag083-B52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.933039","article-title":"The acromegaly lipodystrophy","volume":"13","author":"Freda","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026052910215859600_lvag083-B53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1210\/jc.2005-1280","article-title":"Eotaxin and obesity","volume":"91","author":"Vasudevan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026052910215859600_lvag083-B54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00006676-198808000-00009","article-title":"Novel assay for pancreatic cellular damage: 1.\u2019Characterization of protein profiles in human pancreatic cytosol and purification and characterization of a pancreatic specific protein","volume":"3","author":"Pousette","year":"1988","journal-title":"Pancreas"},{"issue":"4","key":"2026052910215859600_lvag083-B55","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/S0021-9258(18)45919-4","article-title":"Isolation of a cDNA encoding a human serum marker for acute pancreatitis. Identification of pancreas-specific protein as pancreatic procarboxypeptidase B","volume":"267","author":"Yamamoto","year":"1992","journal-title":"J Biol Chem"},{"issue":"1","key":"2026052910215859600_lvag083-B56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2036.1992.tb00543.x","article-title":"Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995)","volume":"6","author":"Kemmer","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2026052910215859600_lvag083-B57","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1046\/j.1440-1746.2001.02499.x","article-title":"Effects and mechanisms of somatostatin analogs on apoptosis of pancreatic acinar cells in acute pancreatitis in mice","volume":"16","author":"Yuan","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2026052910215859600_lvag083-B58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF02915416","article-title":"Effects of somatostatin on somatotroph adenomas of the human pituitary: an in vitro functional and morphological study","volume":"1","author":"Asa","year":"1990","journal-title":"Endocr Pathol"},{"issue":"4","key":"2026052910215859600_lvag083-B59","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13263","article-title":"CD68 + and CD8 + immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs","volume":"35","author":"Chiloiro","year":"2023","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"2026052910215859600_lvag083-B60","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ymthe.2023.12.010","article-title":"Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8(+) T cell activity","volume":"32","author":"Luan","year":"2024","journal-title":"Mol Ther"},{"issue":"Suppl 3","key":"2026052910215859600_lvag083-B61","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1186\/ar570","article-title":"Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha\/beta in immunity and autoimmunity","volume":"4 Suppl 3","author":"McDevitt","year":"2002","journal-title":"Arthritis Res"},{"issue":"1","key":"2026052910215859600_lvag083-B62","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0830-3","article-title":"Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours","volume":"7","author":"Marques","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"2026052910215859600_lvag083-B63","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/EJE-19-0124","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: individualised management of acromegaly","volume":"181","author":"Bollerslev","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026052910215859600_lvag083-B64","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/er.2013-1071","article-title":"Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications","volume":"35","author":"Kamenicky","year":"2014","journal-title":"Endocr Rev"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag083\/68276766\/lvag083.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/5\/732\/68276766\/lvag083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/5\/732\/68276766\/lvag083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:22:04Z","timestamp":1780064524000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/5\/732\/8677041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag083","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,30]]}}}